Market revenue in 2023 | USD 11,493.8 million |
Market revenue in 2030 | USD 17,290.9 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 32.16% in 2023. Horizon Databook has segmented the North America oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounts for 31.5% share in the global oral solid dosage contract manufacturing market owing to growing investments in R&D of new drugs by pharmaceutical companies, which boosts the demand for oral solid dosage contract manufacturing. The growth of pharmaceutical industry in the U.S. and Canada is a key factor contributing to market growth.
The expansion of the market in the region can be attributed to the presence of technologically advanced Contract Manufacturing Organizations (CMOs) & Contract Development and Manufacturing Organizations (CDMOs) and a surge in the allocation of grants.
Furthermore, increasing drug development activities, strategic measures like innovation & acquisitions, the presence of pharmaceutical companies, and a surge in the demand for oral solid dosage products in the region are among key factors propelling the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America oral solid dosage contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account